Cannabis Bioscience International Holdings, Inc. (CBIH)
| Market Cap | 5.81M |
| Revenue (ttm) | 303.02K |
| Net Income (ttm) | -548.82K |
| Shares Out | 11.63B |
| EPS (ttm) | -0.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 500,000 |
| Average Volume | 1,795,125 |
| Open | 0.0005 |
| Previous Close | 0.0006 |
| Day's Range | 0.0005 - 0.0005 |
| 52-Week Range | 0.0004 - 0.0009 |
| Beta | 0.05 |
| RSI | 51.45 |
| Earnings Date | Sep 16, 2025 |
About CBIH
Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education courses for attorneys; certification courses for physicians; certification for industry workers; general education seminars; and on-site training, as well as consulting, digital publishing, marketing, and franchising related to me... [Read more]
Full Company ProfileFinancial Performance
In 2025, CBIH's revenue was $303,022, an increase of 21.77% compared to the previous year's $248,841. Losses were -$548,820, -15.74% less than in 2024.
Financial StatementsNews
CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery
Houston, Texas--(Newsfile Corp. - October 13, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) today announced the addition of a patent-pending nanoemulsion formulation to its gr...
CBIH Ignites Texas: Statewide TCUP Seminar Marks a New Era for Medical Cannabis-With Evidence, Safety, and Patient Dignity at the Center
Houston, Texas--(Newsfile Corp. - September 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) announces a Statewide Educational Seminar Series on the TCUP Expansion, as Texas ...
CBIH Welcomes Charles Tamburello to Its Board, Strengthening M&A Strategy
Houston, Texas--(Newsfile Corp. - November 4, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is thrilled to announce the appointment of Mr. Charles Tamburello as a new member of t...
CBIH Strengthens Competitive Advantage with Rapid Expansion of Patent Filings
Houston, Texas--(Newsfile Corp. - October 28, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) trading on the OTC Markets under the ticker symbol CBIH has reached a major milestone ...
CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications
Cannabis Bioscience International Holdings (OTCMKTS:CBIH) has initiated a strategic move to expand its presence in the cannabis market by filing applicati
CBIH Charts Path to Future Leadership in Cannabis Medicine
A letter from our desk HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Since the start of the year, Cannabis Bioscience International Holdings (OTCMKTS: CBIH) has embarked on a transformative journey invol...
CBIH: Unleashing the Potential of Cannabis for Tomorrow's Medicine
A letter from our desk Houston, Texas--(Newsfile Corp. - July 8, 2024) - Since the start of the year, Cannabis Bioscience International Holdings (OTC Pink: CBIH) has embarked on a transformative journ...
CBIH Submits Groundbreaking Cannabis Patents for Breast and Pancreatic Cancer Treatments
Houston, Texas--(Newsfile Corp. - July 1, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel ...
CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change
As CBIH prepares for the manufacturing and distribution of its products, the potential collaboration might involve this entity acting as CBIH's distributor
CBIH's Recently Appointed Director Unveils Groundbreaking Product Strategies and Potential Partnership with Industry Leader
Houston, Texas--(Newsfile Corp. - June 24, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is thrilled to introduce the groundbreaking strategies formulated by its freshly appointe...
Unleashing the Potential of Cannabis: Cannabis Bioscience International Holdings Reaches a Historic Valuation
HOUSTON, June 17, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH), a company dedicated to medicinal cannabis research for over 15 years, has achieved a 2 bil...
CBIH Achieves $2 Billion Valuation Following StoneBridge Advisory Assessment
Houston, Texas--(Newsfile Corp. - June 17, 2024) - Cannabis Bioscience International Holdings (OTC PINK: CBIH) has been valued at $2 Billion following a rigorous evaluation by StoneBridge Advisory, a ...
CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward
“Collaboration in clinical trials ensures data integrity and safety, advancing both organizations' missions and improving patient care,” says Dr. Jennifer
Vita Biotech Retains CBIH Services for Clinical Studies
Houston, Texas--(Newsfile Corp. - June 5, 2024) - Vita Biotech Research has entered into a significant partnership with Cannabis Bioscience International Holdings (OTC Pink: CBIH), to fund the clinica...
Cannabis Bioscience International Holdings Engages StoneBridge Advisory for Comprehensive Company Valuation
Houston, Texas--(Newsfile Corp. - May 29, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) announces the engagement of StoneBridge Advisory (stonebridgema.com) for CBIH's company va...
CBIH Engages Prestigious Law Firm for its First Patent Applications
Houston, Texas--(Newsfile Corp. - May 20, 2024) - Cannabis Bioscience International Holdings(OTC Pink: CBIH), utilizing robust methodologies to safeguard its intellectual property and establish a well...
CBIH Welcomes New Treasurer and Director, Mr. John E. Jones
Houston, Texas--(Newsfile Corp. - May 6, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH), a leading company in the cannabis industry, proudly announces Mr. John E. Jones as its new...
CBIH Commences Clinical Trials of Osteoarthritis Injection "Orthocann"
Houston, Texas--(Newsfile Corp. - March 20, 2024) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) has announced the enrollment of the first patient for the clinical trial of its ne...
CBIH Announces the Retirement of One Billion Shares
Houston, Texas--(Newsfile Corp. - March 6, 2024) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) announces that Dante Picazo, its chief executive officer, is contributing one billi...
Brian Cuban Joins Cannabis Bioscience International Holdings as an Advisory Board Member
Houston, Texas--(Newsfile Corp. - February 26, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is excited to announce that Brian Cuban has been elected by our firm as an Advisory B...
Cannabis Bioscience International Holdings, Inc. Announces Engagement of Bull in Advantage as its Investor Relations Firm
Houston, Texas--(Newsfile Corp. - February 20, 2024) - Cannabis Bioscience International Holdings, a Houston-based company trading on the OTC Markets under the ticker symbol CBIH, has engaged the serv...
A Letter From Cannabis Bioscience International Holdings CEO Dante Picazo Regarding Actual Progress and Plans for 2024
Houston, Texas--(Newsfile Corp. - December 18, 2023) - Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH). CEO Dante Picazo sending a letter to all shareholders.
Texas Has Given Birth to Its First and Only Global Publicly Traded Cannabis Company, Cannabis Bioscience International Holdings
This Calls for a Celebration Houston, Texas--(Newsfile Corp. - December 15, 2023) - On December 5, 2023, Cannabis Bioscience International Holdings (OTC Pink: CBIH) , a Houston, TX, based company, tra...
Cannabis Bioscience International Holdings Announces Effectiveness of Form S-1 Registration Statement
HOUSTON, TX , Dec. 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) announces that its registration statement on Form S-1 (File No. 333...
Cannabis Bioscience International Holdings (CBIH) Unveils Its Rebranding Through Its New and Innovative Website
HOUSTON, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Cannabis Bioscience International Holdings (trading on the OTC Markets under the ticker symbol CBIH), a medical research company ...